Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy
Article in Scientific Reports (March 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial
Article in Breast Cancer Research (January 2024)
The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review
Article in Frontiers in Oncology (October 2023)